Oaktree Acquisition Corp. III Life Sciences Unit Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 516.48 K | $5.48 M | 0.00% | 2.69% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 250.00 K | $2.66 M | 0.00% | 1.30% |
| ATHOS CAPITAL LTD | 11/13/2025 | 50.00 K | $533.00 K | 0.00% | 0.26% |
| CLEAR STREET GROUP INC. | 11/14/2025 | 20.33 K | $216.55 K | 100.00% | 0.11% |
| UBS GROUP AG | 11/13/2025 | 9.78 K | $103.80 K | 0.00% | 0.05% |
| CITIGROUP INC | 11/10/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Oaktree Acquisition Corp. III Life Sciences Unit institutional Ownership - FAQ's
During the previous two years, 7 institutional investors and hedge funds held shares of Oaktree Acquisition Corp. III Life Sciences Unit. The most heavily invested institutionals were:
ADAR1 Capital Management, LLC: 516,482
Affinity Asset Advisors, LLC: 250,000
Athos Capital Ltd: 50,000
Clear Street Group Inc.: 20,333
UBS Group AG: 9,783
CITIGROUP INC: 0
4.41% of Oaktree Acquisition Corp. III Life Sciences Unit stock is owned by institutional investors.
Institutional investors have bought a total of 867.42 K shares in the last 24 months. This purchase volume represents approximately $9.28 M in transactions.